GLP-1 Patient Populations
Explore peptide research and guides on glp-1 patient populations.
GLP-1 Patient Populations
Do GLP-1 Drugs Work Differently by Race?
GLP-1 drugs show consistent weight loss across racial groups in trials, but major prescribing disparities exist. Here is what the subgroup data shows.
GLP-1 Patient PopulationsWho Qualifies for GLP-1 Weight Loss Drugs?
FDA criteria require BMI ≥30 or ≥27 with comorbidities for GLP-1 drugs. But insurance, the WHO, race, and age all draw different eligibility lines.